The Effect of Postpartum Debriefing on the Psychological Outcomes
Launched by MERSIN UNIVERSITY · Feb 7, 2025
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how talking about and reinterpreting the experience of childbirth in the early days after delivery can affect new mothers’ feelings and mental health. The focus is on understanding whether this process can help reduce fears about childbirth, lessen symptoms of postpartum depression, and address any trauma related to the birth experience.
To participate in this study, women must be aged between 18 and 45, speak Turkish, and be pregnant for the first time (this means they have never given birth before). They should be in good health and at least 37 weeks pregnant, planning to give birth at Tarsus State Hospital. Participants will have a conversation with a researcher about their birth experience during the first 24 hours after delivery. It’s important to note that women with certain complications or who have had an emergency cesarean section, among other criteria, won’t be eligible to join the study. If they choose to participate, they can expect support and a safe space to discuss their feelings about childbirth.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who volunteer to participate in the study, Whose mother tongue is Turkish, Who are between the ages of 18-45, Who are at least primary school graduates, Who are 37-42 weeks pregnant, Who are nulliparous, Who have a healthy pregnancy, Who do not have a psychological condition or psychiatric disorder, Who are monitored and cared for in the first 24 hours after birth at the Tarsus State Hospital Maternity Department, Who approve of the reinterpretation of birth application to be carried out by the researcher will be included in the sample.
- Exclusion Criteria:
- • Those who did not volunteer to participate in the study, Those who gave birth before the 37th week of pregnancy, Those who were multiparous, Those who had abnormal medical conditions during pregnancy (placental disorder, preeclampsia, premature birth threat, etc.),
- • Those whose native language is not Turkish, Those who have visual, speech and hearing impairments, Those who had an emergency cesarean section, Those who stayed in the hospital for less than 12 hours after birth, Those who received a psychiatric diagnosis during the postpartum period (except those diagnosed with postpartum depression and post-traumatic stress disorder related to birth), Those who could not be reached by phone during the follow-up of the study, Women who developed complications in the first 24 hours after birth and required intensive care, Those whose babies required neonatal intensive care during the postpartum period, Those who experienced another life event that traumatized the woman during the postpartum period (harassment, rape, earthquake, accident, loss of a loved one) etc.) Those who want to withdraw from the study at any stage of the study will not be included in the sample.
About Mersin University
Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mersin, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported